27 min readLast updated July 2026Beginner levelOfficial-source checked
A patient-friendly, evidence-based guide to AS and axial spondyloarthritis treatment in 2026: NSAIDs, biologics, IL-17 inhibitors, JAK inhibitors, biosimilars, switching, safety checks, and the questions to bring your rheumatologist.
A patient-friendly, evidence-based guide to AS and axial spondyloarthritis treatment in 2026: NSAIDs, biologics, IL-17 inhibitors, JAK inhibitors, biosimilars, switching, safety checks, and the questions to bring your rheumatologist.
Sign in or create a free account
A free reader account lets you read two articles a day, save pieces for later, and join the conversation.
